1. Market Research
  2. > Pharmaceutical
  3. > Pathology Market Trends
  4. > Pathology Analysis & Statistics, June 2015 (p4)

Pathology Analysis & Statistics, June 2015 (p4)

24/7 Customer Support

Talk to Amrita

+33 9 73 87 19 47

Publishers

All regions

91-120 of about 7 400 reports

Purchase Reports From Reputable Market Research Publishers

Proteins in Oncology Drug Pipeline Update 2015

Proteins in Oncology Drug Pipeline Update 2015

  • € 2 093
  • Industry report
  • June 2015
  • by Bioseeker

This drug pipeline update covers proteins, excluding antibodies, as drugs for the treatment of cancer. There are today 412 companies plus partners developing 457 protein drugs in 944 developmental projects ...

  • Industries : Pathology
TSH Signaling Pathway in Oncology Drug Pipeline Update 2015

TSH Signaling Pathway in Oncology Drug Pipeline Update 2015

  • € 2 093
  • Industry report
  • June 2015
  • by Bioseeker

Human thyroid stimulating hormone (TSH) exerts its action through various signaling cascades such as cAMP cascade and the phospholipase C beta-mediated inositol phosphate generation. Further, it will give ...

  • Industries : Pathology
GnRH Signaling Pathway in Oncology Drug Pipeline Update 2015

GnRH Signaling Pathway in Oncology Drug Pipeline Update 2015

  • € 2 093
  • Industry report
  • June 2015
  • by Bioseeker

Gonadotropin-releasing hormone (GnRH) secretion from the hypothalamus acts upon its receptor in the anterior pituitary to regulate the production and release of the gonadotropins, LH and FSH. There are ...

  • Industries : Pathology
Notch Signaling Pathway in Oncology Drug Pipeline Update 2015

Notch Signaling Pathway in Oncology Drug Pipeline Update 2015

  • € 2 093
  • Industry report
  • June 2015
  • by Bioseeker

Aberrant Notch signaling has been linked to a number of malignancies including leukemias, lymphomas and carcinomas of the breast, skin, lung, cervix and kidneys. There are today 309 companies plus partners ...

  • Industries : Pathology
Peptides in Oncology Drug Pipeline Update 2015

Peptides in Oncology Drug Pipeline Update 2015

  • € 2 093
  • Industry report
  • June 2015
  • by Bioseeker

There are today 305 companies plus partners developing 292 peptide drugs in 780 developmental projects in cancer. In addition, there are 5 suspended drugs and the accumulated number of ceased drugs ove ...

  • Industries : Pathology
HIF-1 Signaling Pathway in Cancer Drug Pipeline Update 2015

HIF-1 Signaling Pathway in Cancer Drug Pipeline Update 2015

  • € 2 093
  • Industry report
  • June 2015
  • by Bioseeker

Cancer cells are characterized by rapid proliferation and require adaptive metabolic responses to allow continued biosynthesis and cell growth in the setting of decreased oxygen (O(2)) and nutrient availability. ...

  • Industries : Pathology
TSLP Signaling Pathway in Oncology Drug Pipeline Update 2015

TSLP Signaling Pathway in Oncology Drug Pipeline Update 2015

  • € 2 093
  • Industry report
  • June 2015
  • by Bioseeker

Thymic stromal lymphopoietin (TSLP) is an IL-7-like cytokine that play various roles in a broad spectrum of biological procedures. TSLP can be secreted by epithelial cells upon pathogen stimulation. TSLP ...

  • Industries : Pathology
Renal Cancer Drug Pipeline Update 2015

Renal Cancer Drug Pipeline Update 2015

  • € 2 093
  • Industry report
  • June 2015
  • by Bioseeker

The high existing unmet need in the treatment of renal cancer is reflected by the poor prognosis of patients with advanced stage disease, five- year survival rates with existing cytokine therapy being ...

  • Industries : Pathology
Targeting Immune Checkpoints in Cancer Immunotherapy Drug Pipeline Update 2015

Targeting Immune Checkpoints in Cancer Immunotherapy Drug Pipeline Update 2015

  • € 2 093
  • Industry report
  • June 2015
  • by Bioseeker

BioSeeker’s Targeting Immune Checkpoints in Cancer Immunotherapy: Drug Pipeline Update is the most up to date and comprehensive pipeline review and competitive assessment you can get on this hot and ...

  • Industries : Pathology
Transcriptional Misregulation in Cancer Drug Pipeline Update 2015

Transcriptional Misregulation in Cancer Drug Pipeline Update 2015

  • € 2 093
  • Industry report
  • June 2015
  • by Bioseeker

There are today 272 companies plus partners developing 323 transcriptional misregulation targeting drugs in 1367 developmental projects in cancer. In addition, there are 5 suspended drugs and the accumulated ...

  • Industries : Pathology
Apoptosis in Oncology Drug Pipeline Update 2015

Apoptosis in Oncology Drug Pipeline Update 2015

  • € 2 093
  • Industry report
  • June 2015
  • by Bioseeker

Cancer cells frequently and possibly invariably possess apoptotic defects. In this context, apoptotic pathways provide exciting molecular targets for new therapeutic agents to specifically promote apoptosis ...

  • Industries : Pathology
Colorectal Cancer Drug Pipeline Update 2015

Colorectal Cancer Drug Pipeline Update 2015

  • € 2 093
  • Industry report
  • June 2015
  • by Bioseeker

Until a decade ago, 5FU/leucovorin formed the mainstay of colorectal cancer treatment but Camptosar and Eloxatin quickly established themselves as components of gold-standard therapy. The advent of Avastin ...

  • Industries : Pathology
Conjugated Drugs in Oncology Drug Pipeline Update 2015

Conjugated Drugs in Oncology Drug Pipeline Update 2015

  • € 2 093
  • Industry report
  • June 2015
  • by Bioseeker

Among conjugated drugs in oncology, antibody-drug conjugates (ADCs) are by far getting the most attention as a new drug class. Owing to improved technology and appropriate targeting, the clinical application ...

  • Industries : Pathology
Antibodies in Oncology Drug Pipeline Update 2015

Antibodies in Oncology Drug Pipeline Update 2015

  • € 2 093
  • Industry report
  • June 2015
  • by Bioseeker

The commercial and therapeutic success of antibodies like Rituxan, Avastin, and Erbitux will force the industry to look into the next generation of therapeutic antibodies, preparing themselves for the ...

  • Industries : Pathology
Kit Receptor Signaling Pathway in Oncology Drug Pipeline Update 2015

Kit Receptor Signaling Pathway in Oncology Drug Pipeline Update 2015

  • € 2 093
  • Industry report
  • June 2015
  • by Bioseeker

The Kit receptor signaling pathway includes activation of PI 3-kinase, Src family kinases and PLC gamma. Activating mutations in the Kit receptor are associated with several human malignancies include ...

  • Industries : Pathology
Lymphoma Drug Pipeline Update 2015

Lymphoma Drug Pipeline Update 2015

  • € 2 093
  • Industry report
  • June 2015
  • by Bioseeker

Lymphoma is a broad term encompassing a variety of cancers of the lymphatic system. There are today 339 companies plus partners developing 464 lymphoma drugs in 884 developmental projects in cancer. In ...

  • Industries : Pathology
Ovarian Cancer Drug Pipeline Update 2015

Ovarian Cancer Drug Pipeline Update 2015

  • € 2 093
  • Industry report
  • June 2015
  • by Bioseeker

With nearly 60,000 cases of ovarian cancer being diagnosed in the seven major markets each year, this cancer type is by no means small and therefore it remains an important secondary indication for existing ...

  • Industries : Pathology
mTOR Signaling Pathway in Oncology Drug Pipeline Update 2015

mTOR Signaling Pathway in Oncology Drug Pipeline Update 2015

  • € 2 093
  • Industry report
  • June 2015
  • by Bioseeker

The mammalian target of rapamycin (mTOR) is an intracellular kinase that controls the production of proteins through its regulation of translational machinery. mTOR-activated proteins promote several hallmarks ...

  • Industries : Pathology
Cancer Stem Cells Drug Pipeline Update 2015

Cancer Stem Cells Drug Pipeline Update 2015

  • € 2 093
  • Industry report
  • June 2015
  • by Bioseeker

Treatments designed to target and destroy cancer stem cells may come to revolutionize how we treat cancer. This unique product covers both explicit cancer stem cell drug development and cancer drugs which ...

  • Industries : Pathology
Brain Cancer Drug Pipeline Update 2015

Brain Cancer Drug Pipeline Update 2015

  • € 2 093
  • Industry report
  • June 2015
  • by Bioseeker

Despite the heavy investment made into brain cancer research, primary brain cancer, with glioblastoma multiforme being the most aggressive and most common form, remains one of the most deadly diseases ...

  • Industries : Pathology
Cancer Vaccines Drug Pipeline Update 2015

Cancer Vaccines Drug Pipeline Update 2015

  • € 2 093
  • Industry report
  • June 2015
  • by Bioseeker

Cancer vaccines offer an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. However, despite years of R&D, a reproducible survival benefit has ...

  • Industries : Pathology
2015 Market Research Report on Global Insulin Industry

2015 Market Research Report on Global Insulin Industry

  • € 2 080
  • Industry report
  • April 2015
  • by QY Research Group

Summary 2015 Market Research Report on Global Insulin Industry is a professional and deep research report in this field. For overview analysis, the report introduces Insulin basic information including ...

  • Industries : Pathology, Drug and Medication, Pharmaceutical
  • Countries : World, China
Global Neurostimulation Devices Market 2015

Global Neurostimulation Devices Market 2015

  • € 2 000
  • Industry report
  • June 2015
  • by Infiniti Research Limited

About Neurostimulation Devices Available pharmacological treatment for conditions such as chronic pain, epilepsy, Parkinson’s disease, and depression are not sufficient for all patients at all stages ...

  • Industries : Pathology
  • Countries : World
Global HPV Testing Market 2015-2019

Global HPV Testing Market 2015-2019

  • € 2 000
  • Industry report
  • June 2015
  • by Infiniti Research Limited

About HPV HPV refers to a group of more than 200 related viruses commonly causing infections that do not have any symptoms. Among these, more than 40 types of HPV cause highly contagious diseases that ...

  • Industries : Pathology
  • Countries : World
Global Restless Legs Syndrome Market 2015-2019

Global Restless Legs Syndrome Market 2015-2019

  • € 2 000
  • Industry report
  • June 2015
  • by Infiniti Research Limited

About RLS RLS is a neurological disease; it is also known as Willis-Ekbom disease. People with RLS experience an overwhelming desire to move their legs. It leads to an unpleasant pain in the limbs, leading ...

  • Industries : Pathology
  • Countries : World
Global Heparin Market 2015-2019

Global Heparin Market 2015-2019

  • € 2 000
  • Industry report
  • June 2015
  • by Infiniti Research Limited

About Heparin Heparin is an anticoagulant or blood thinner produced by basophils and mast cells. Though it has no effect on already formed clots, it enables the body's natural clot lysis mechanisms to ...

  • Industries : Pathology
  • Countries : World
Global Benign Prostatic Hyperplasia Devices Market  2015-2019

Global Benign Prostatic Hyperplasia Devices Market 2015-2019

  • € 2 000
  • Industry report
  • June 2015
  • by Infiniti Research Limited

About Benign Prostatic Hyperplasia Device Benign prostatic hyperplasia is a condition characterized by non-cancerous proliferation of prostate gland cells. This causes the gland to enlarge and, as a result, ...

  • Industries : Pathology
Peritonitis Global Clinical Trials Review, H1, 2015

Peritonitis Global Clinical Trials Review, H1, 2015

  • € 2 000
  • Industry report
  • May 2015
  • by Global Data

Peritonitis Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Peritonitis Global Clinical Trials Review, H1, 2015" provides an overview of Peritonitis clinical trials ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Pathology, Therapy
  • Countries : World
Cellulitis Global Clinical Trials Review, H1, 2015

Cellulitis Global Clinical Trials Review, H1, 2015

  • € 2 000
  • Industry report
  • May 2015
  • by Global Data

Cellulitis Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Cellulitis Global Clinical Trials Review, H1, 2015" provides an overview of Cellulitis clinical trials ...

  • Industries : Pharmaceutical, Pathology, Drug Discovery and Development, Therapy
  • Countries : World
Abscess Global Clinical Trials Review, H1, 2015

Abscess Global Clinical Trials Review, H1, 2015

  • € 2 000
  • Industry report
  • May 2015
  • by Global Data

Abscess Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Abscess Global Clinical Trials Review, H1, 2015" provides an overview of Abscess clinical trials scenario. ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Therapy
  • Countries : World

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.